Antisoma 01/09/2010
Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.
Growth Company Investor - Stock market recommendations on AIM and small cap companies
Popular Topics within deals & contracts
GW Pharmaceuticals 31/08/2010
GW Pharmaceuticals has won approval from Health Canada for its cannabis-based Sativex product to treat spasticity caused by Multiple Sclerosis.
Beowulf Mining 27/08/2010
Sweden-focused Beowulf Mining will drill soon at its Routevare iron ore project after a 17% first-half loss increase to £222,000.
Brainspark 17/08/2010
Ambitious investment minnow Brainspark is looking forward to the £25m Milan flotation of its key Italian leisure park holding Mediapolis.
Allocate Software 17/08/2010
Workforce and compliance optimisation specialist Allocate offers exposure to fast-paced organic and acquisitive growth at a very reasonable price indeed.
Proximagen 11/08/2010
Prospects at cash-rich drug discoverer Proximagen, which focuses on neurological diseases including Parkinson's, have been boosted by the signing of a deal with the National Institute of Health in the United States.
Bglobal: a smart bet on green energy drive 13/08/2010
Our need for energy – secure, sustainable and, crucially, affordable – has never ranked as highly on the global political agenda. What’s more, these exceptionally straitened times are causing organisations large and small to rigorously examine their outgoings. So it stands to reason that any company that can help businesses both cut costs and reduce their carbon footprint should be well placed for profitable growth.
Big contracts still beckon Lamprell 13/08/2010
Nigel McCue, CEO of Lamprell, a leading provider of engineering services to the oil and gas industry, is one experienced industry hand who suspects BP’s traumatic rig disaster in the Gulf of Mexico could have long-term benefits for his company. He suggests that it will lead to tougher mandatory safety measures and features.
Matchtech 09/08/2010
In its latest trading update, technical recruiter Matchtech has reported a 14% fall in net fee income for the year to July.
Intandem Films
28/07/2010
Having cleared its debts, AIM-quoted film financing, sales and marketing company Intandem could be set to become more than a penny stock.
Lamprell 28/07/2010
Engineering services group Lamprell has won a new $317m (£204m) contract with the National Drilling Company of Abu Dhabi.
Nationwide Accident Repair Services 22/07/2010
Nationwide, the country’s largest dedicated car crash repair services firm, is successfully motoring ahead with its new three-year strategy for growth.
Advertisement
Learn what the smart money is doing
We have a fantastic opportunity for you to attend the Traders Secrets Seminar to learn from our professional traders how it is possible to generate an instant income through trading.
Financial trading and sports betting with Spreadex
Trade the markets, place sports spread bets and fixed odds bets all from the same account.
Click here now for up to £400* of offers. *Ts&cs apply. http://www.spreadex.com/financials
VCT Report 2010
VCT Report 2010 uncovers the money available
for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted
company.
Order VCT Report 2010 today using this online form
Cash Shells Directory 2010
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Business XL Magazine
Business XL is written by leaders for leaders. The magazine is a fountain of inside information and knowledge, which can only be delivered by people who have started, bought and grown their own business.
The Financial Times Guide to Personal Tax
is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Take control of your investments
A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.
The AIM Guide Spring 2010
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Coverage of AIM, techMARK and PLUS Markets
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
Popular Topics
Acquisitions
Aim
Boardroom Moves
Breaking-even
Buy/hold
Cash
China
Commodities
Credit Crunch
Deals & Contracts
Debt
Defensive
Director Dealing
Dividends
Domestic Goods
Downgrades
Emerging Markets
Full List
Fundraisings
Gold
Growth Stocks
Mergers & Acquisitions
Mining
New Issues
Penny Shares
Plus Markets
Profit Warnings
Renewables
Restructuring
Sell/avoid
Small-cap
Speculative Punts
Technology
Turnaround
Undervalued
Advertisement
Sectors
Aerospace & Defence
Alternative Energy
Automobiles & Parts
Banks
Beverages
Chemicals
Construction & Materials
Electricity
Electronic & Electrical Equipment
Equity Investment Instruments
Fixed Line Telecommunications
Food & Drug Retailers
Food Producers
Forestry & Paper
Gas, Water & Multiutilities
General Financial
General Industrials
General Retailers
Health Care Equipment & Services
Household Goods
Industrial Engineering
Industrial Metals
Industrial Transportation
Leisure Goods
Life Insurance
Media
Mining
Mobile Telecommunications
Nonequity Investment Instruments
Nonlife Insurance
Oil & Gas Producers
Oil Equipment, Services & Distribution
Personal Goods
Pharmaceuticals & Biotechnology
Real Estate
